14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
KBA vs KURE: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, KraneShares MSCI All China Health Care Index ETF (KURE) is the stronger overall head-to-head candidate over KraneShares Bosera MSCI China A 50 Connect Index ETF (KBA) in the Tradestie Institutional Equity Comparison Engine, winning 2–1 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). KBA carries a Unified Composite Score of 44.0/100 (HOLD) at $27.83 (N/M Forward P/E, N/A operating margin), whereas KURE carries 50.9/100 (HOLD) at $17.81 (N/M Forward P/E, N/A operating margin).
Technical & Structure Timing Caution: KBA is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 33.6); meanwhile KURE is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 43.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on KBA vs KURE. Trailing 12-month operating profitability (KBA N/A vs KURE N/A) and valuation multiples (KBA N/M vs KURE N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ KBA vs KURE Key Questions & Quantitative Answers
As of Nov 16, 2026, KraneShares MSCI All China Health Care Index ETF (KURE) is the stronger overall head-to-head candidate over KraneShares Bosera MSCI China A 50 Connect Index ETF (KBA) in the Tradestie Institutional Equity Comparison Engine, winning 2–1 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). KBA carries a Unified Composite Score of 44.0/100 (HOLD) at $27.83 (N/M Forward P/E, N/A operating margin), whereas KURE carries 50.9/100 (HOLD) at $17.81 (N/M Forward P/E, N/A operating margin). Technical & Structure Timing Caution: KBA is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 33.6); meanwhile KURE is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 43.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
KBA and KURE split Growth & Scale metrics: KBA posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with KURE at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, KBA generates N/A in USD-normalized revenue versus N/A for KURE. In operating R&D and SG&A reinvestment, KBA deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for KURE.
KBA and KURE trade at balanced relative valuation multiples. KBA trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas KURE trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against KBA (N/A ROE) versus KURE (N/A ROE) capital efficiency.
In options market volatility and institutional positioning, KBA carries 37.1% implied volatility (23rd %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.85β · 19% Vol realized risk). By comparison, KURE carries 28.0% implied volatility (<1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.73β · 32% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.